Genzyme Asks To Add New Patent To Arthritis Drug Suit
Genzyme Corp. sought Tuesday to add a newly issued patent to its ongoing infringement battle with Anika Therapeutics Inc. in Massachusetts federal court over Anika's osteoarthritis drug Monovisc....To view the full article, register now.
Already a subscriber? Click here to view full article